Results 121 to 130 of about 64,904 (211)

Prompt-based multimodal representation learning for drug repurposing. [PDF]

Brief Bioinform
Liu J, U K, Rana D, Meixuan Zhang S, Yu J, Yang S, Jin B, Wang X, Yang Z, Tang H, Zhao J.   +10 more
europepmc   +1 more source

Protein kinase A is a dependent factor and therapeutic target in mouse models of fibrous dysplasia. [PDF]

Nat Commun
Liu Z, Xing L, Huang W, Ji N, Zhao H, Chen Q, Han X, Bai D, Zhao X.   +8 more
europepmc   +1 more source

A lightweight zero-trust authentication architecture for IoT via unified enhanced FAST-SM9 and dynamic re-authentication. [PDF]

PLoS One
Ma Z, Wei H, Jiang J, Wang B, Wang H, Di Z.   +5 more
europepmc   +1 more source

IBS-ECDHE: A blockchain-enhanced lightweight protocol for secure cloud-IoT in biomedical HCPS. [PDF]

Comput Struct Biotechnol J
Rehman AU, Lu S, Usman M, Moqurrab SA, Srivastava G, Yoo J, Al-Aqrabi H.   +6 more
europepmc   +1 more source

A Pharmacologic Approach Against Glioblastoma-A Synergistic Combination of a Quinoxaline-Based and a PI3K/mTOR Dual Inhibitor. [PDF]

Int J Mol Sci
de São José VS, Vieira BM, de Figueiredo CS, Valdivieso Gelves LG, Neto VM, Lima LM.   +5 more
europepmc   +1 more source

From in-silico QSAR modeling to in-vitro MTT assay: experimental validation of novel uPAR leads for triple-negative breast cancer (TNBC) and skin cancer. [PDF]

Sci Rep
Badukle H, Jawarkar RD, Shah U, Chaudhary S, Alzahrani AYA, Samad A, Al-Hussain SA, Al-Mutairi AA, Zaki MEA.   +8 more
europepmc   +1 more source

Views of European Union medicine regulators and healthcare professionals on the approved versus prescribed dose of protein kinase inhibitors: an interview study. [PDF]

BMJ Open
Brinkhof M, de Vries ST, Mol PGM, Trapani D, Marije de Jong I, Broekman KE.   +5 more
europepmc   +1 more source

Comparative analysis of molecular targeted radiosensitizers in 2D and 3D cancer cell line models. [PDF]

Acta Oncol
Ramirez Parra M, Dietrich A, Pfeifer M, Willers H, Krause M, Borgeaud N.   +5 more
europepmc   +1 more source

Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy. [PDF]

United European Gastroenterol J
Beutel AK, Halbrook CJ, Ekizce M, Lindenmayer J, Roger E, Calderon SE, Seufferlein T, Kleger A, Gout J, Perkhofer L.   +9 more
europepmc   +1 more source

Blockchain-Enabled Identity Based Authentication Scheme for Cellular Connected Drones. [PDF]

Sensors (Basel)
Su Y, Li Z, Zhang Y, Gui X, Deng X, Fu J.   +5 more
europepmc   +1 more source